Search Results - "Digiusto, D"

Refine Results
  1. 1

    Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion by Kumar, B, Garcia, M, Weng, L, Jung, X, Murakami, J L, Hu, X, McDonald, T, Lin, A, Kumar, A R, DiGiusto, D L, Stein, A S, Pullarkat, V A, Hui, S K, Carlesso, N, Kuo, Y-H, Bhatia, R, Marcucci, G, Chen, C-C

    Published in Leukemia (01-03-2018)
    “…Little is known about how leukemia cells alter the bone marrow (BM) niche to facilitate their own growth and evade chemotherapy. Here, we provide evidence that…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma by Cooper, L.J.N., Ausubel, L., Gutierrez, M., Stephan, S., Shakeley, R., Olivares, S., Serrano, L.M., Burton, L., Jensen, M.C.V., Forman, S.J., Digiusto, D.L.

    Published in Cytotherapy (Oxford, England) (2006)
    “…The production of therapeutic T-cell populations for adoptive immunotherapy of cancer requires extensive ex vivo cell processing, including the isolation or…”
    Get full text
    Journal Article
  4. 4

    Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials by Digiusto, D.L., PhD, Cooper, L.J.N., MD, PhD

    Published in Cytotherapy (Oxford, England) (2007)
    “…The production of clinical-grade T cells for adoptive immunotherapy has evolved from the ex vivo numerical expansion of tumor-infiltrating lymphocytes to…”
    Get full text
    Journal Article
  5. 5

    Hematopoietic Potential of Cryopreserved and Ex Vivo Manipulated Umbilical Cord Blood Progenitor Cells Evaluated In Vitro and In Vivo by DiGiusto, David L., Lee, Robert, Moon, James, Moss, Katherine, O'Toole, Tom, Voytovich, Amy, Webster, Donna, Mule, James J.

    Published in Blood (15-02-1996)
    “…The hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood (UCB) samples was evaluated in vitro and in vivo. Phenotypic analysis…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells by Plavec, I, Voytovich, A, Moss, K, Webster, D, Hanley, M B, Escaich, S, Ho, K E, Böhnlein, E, DiGiusto, D L

    Published in Gene therapy (01-08-1996)
    “…The expression of antiviral genes in human hematopoietic stem or progenitor cells has been proposed as a strategy for gene therapy of AIDS. To be successful,…”
    Get more information
    Journal Article
  8. 8

    Single cell analysis of calcium mobilization in anti-immunoglobulin- stimulated B lymphocytes by Ransom, JT, DiGiusto, DL, Cambier, JC

    Published in The Journal of immunology (1950) (01-01-1986)
    “…A rapid increase in the concentration of intracellular free calcium ([Ca++i]) in B cells after mIg crosslinking has been documented previously by fluorimetric…”
    Get full text
    Journal Article
  9. 9

    Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy by Chung, Janet, Zhang, Jane, Li, Haitang, Ouellet, Dominique L, DiGiusto, David L, Rossi, John J

    Published in Human gene therapy (01-11-2012)
    “…Combinational therapy with small RNA inhibitory agents against multiple viral targets allows efficient inhibition of viral production by controlling gene…”
    Get more information
    Journal Article
  10. 10

    mIgM:mIgD ratios on B cells: mean mIgD expression exceeds mIgM by 10- fold on most splenic B cells by Havran, WL, DiGiusto, DL, Cambier, JC

    Published in The Journal of immunology (1950) (01-04-1984)
    “…The relative frequency of mIgM and mIgD molecules on B cell surfaces is important in determining, in large part, the isotype involvement in antigen binding and…”
    Get full text
    Journal Article
  11. 11

    Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy : An approach to improving product safety, composition, and production capacity by TRAN, Chy-Anh, BURTON, Luciana, RUSSOM, Diana, WAGNER, Jamie R, JENSEN, Michael C, FORMAN, Stephen J, DIGIUSTO, David L

    Published in Journal of immunotherapy (1997) (01-09-2007)
    “…We have developed an innovative system for ex vivo processing of patient-specific cell products to produce large numbers of T-lymphocytes in support of phase 2…”
    Get full text
    Journal Article
  12. 12

    Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies by Cooper, Laurence J.N., Al-Kadhimi, Zaid, DiGiusto, David, Kalos, Michael, Colcher, David, Raubitschek, Andrew, Forman, Steve J., Jensen, Michael C.

    Published in Blood cells, molecules, & diseases (01-07-2004)
    “…The graft-versus-leukemia (GVL)-effect achieved by donor-derived T cells arising from transplanted allogeneic hematopoietic stem cells or given as…”
    Get full text
    Journal Article
  13. 13

    Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus toxin superantigens by Choi, Yongwon, Herman, Andrew, DiGiusto, David, Wade, Terri, Marrack, Philippa, Kappler, John

    Published in Nature (London) (02-08-1990)
    “…The alpha beta T-cell antigen receptor (TCR) recognizes antigenic peptides in the context of self major histocompatibility complex (MHC) molecules. The…”
    Get full text
    Journal Article
  14. 14

    Ex vivo expansion of transplantable human hematopoietic stem cells: where do we stand in the year 2000? by Shih, C C, DiGiusto, D, Forman, S J

    “…Ex vivo expansion of hematopoietic precursors, progenitors and stem cells represents the modern era of cellular therapeutics in the 21st century. For the last…”
    Get more information
    Journal Article
  15. 15

    Analysis of human hematopoietic stem cell populations by Murray, L, DiGiusto, D, Chen, B, Chen, S, Combs, J, Conti, A, Galy, A, Negrin, R, Tricot, G, Tsukamoto, A

    Published in Blood cells (1994)
    “…Purification of human hematopoietic stem cells (HSC) may be useful clinically for preparation of tumor-free grafts to be used for autologous transplantation…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34 by DIGIUSTO, D, CHEN, S, COMBS, J, WEBB, S, NAMIKAWA, R, TSUKAMOTO, A, CHEN, B. P, GALY, A. H. M

    Published in Blood (15-07-1994)
    “…Experimentation on human stem cells is hampered by the relative paucity of this population and by the lack of assays identifying multilineage differentiation,…”
    Get full text
    Journal Article
  18. 18

    Retention of Quiescent Hematopoietic Cells With High Proliferative Potential During Ex Vivo Stem Cell Culture by Young, Judy C., Varma, Amit, DiGiusto, David, Backer, Mark P.

    Published in Blood (15-01-1996)
    “…Human CD34+/Thy-1+/Lin- hematopoietic cells purified from bone marrow (BM) or mobilized peripheral blood (MPB) are highly enriched for pluripotent stem cells…”
    Get full text
    Journal Article
  19. 19

    Hematopoietic Potential of Neural Stem Cells: Plasticity Versus Heterogeneity by Shih, Chu-chih, DiGiusto, David, Mamelak, Adam, LeBon, Thomas, Forman, Stephen J.

    Published in Leukemia & lymphoma (01-01-2002)
    “…Organ-specific stem cells have been identified in a variety of mammalian tissues. These cells hold great promise for cellular therapy if they can reliably…”
    Get full text
    Journal Article
  20. 20

    An analysis of sequence variation in the beta chain framework and complementarity determining regions of an allo-reactive T cell receptor by DiGiusto, D L, Palmer, E

    Published in Molecular immunology (01-06-1994)
    “…Current models of T cell receptor (TCR) structure are generally based on the homology observed between the TCR and the immunoglobulins. Furthermore, these…”
    Get more information
    Journal Article